175 related articles for article (PubMed ID: 16534723)
1. Pharmacokinetic characteristics and hepatic distribution of IH-901, a novel intestinal metabolite of ginseng saponin, in rats.
Lee PS; Song TW; Sung JH; Moon DC; Song S; Chung YB
Planta Med; 2006 Feb; 72(3):204-10. PubMed ID: 16534723
[TBL] [Abstract][Full Text] [Related]
2. In vitro antigenotoxic activity of novel ginseng saponin metabolites formed by intestinal bacteria.
Lee BH; Lee SJ; Hur JH; Lee S; Sung JH; Huh JD; Moon CK
Planta Med; 1998 Aug; 64(6):500-3. PubMed ID: 9741293
[TBL] [Abstract][Full Text] [Related]
3. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
Lee PS; Han JY; Song TW; Sung JH; Kwon OS; Song S; Chung YB
Int J Pharm; 2006 Jun; 316(1-2):29-36. PubMed ID: 16574357
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability and pharmacokinetic studies of eurycomanone from Eurycoma longifolia.
Low BS; Ng BH; Choy WP; Yuen KH; Chan KL
Planta Med; 2005 Sep; 71(9):803-7. PubMed ID: 16206032
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic characterization of ginsenoside Rh2, an anticancer nutrient from ginseng, in rats and dogs.
Gu Y; Wang GJ; Sun JG; Jia YW; Wang W; Xu MJ; Lv T; Zheng YT; Sai Y
Food Chem Toxicol; 2009 Sep; 47(9):2257-68. PubMed ID: 19524010
[TBL] [Abstract][Full Text] [Related]
6. Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat.
Liu J; Kraut EH; Balcerzak S; Grever M; D'Ambrosio S; Chan KK
Cancer Chemother Pharmacol; 2002 Dec; 50(6):445-53. PubMed ID: 12451470
[TBL] [Abstract][Full Text] [Related]
7. High performance liquid chromatographic analysis an pharmacokinetic characteristics of ID-7181, a novel quaternary ammoniopropenyl cephalosporin, following intravenous and intramuscular injections to rats.
Yoo BI; Yeom ZH; Kanga MH; Kwon OS; Kang JH; Yu SW; Moon DC; Song S; Chung YB
Arzneimittelforschung; 2005; 55(9):549-56. PubMed ID: 16229120
[TBL] [Abstract][Full Text] [Related]
8. Extremely low bioavailability of magnesium lithospermate B, an active component from Salvia miltiorrhiza, in rat.
Zhang Y; Akao T; Nakamura N; Duan CL; Hattori M; Yang XW; Liu JX
Planta Med; 2004 Feb; 70(2):138-42. PubMed ID: 14994191
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of desethylamiodarone in the rat after its administration as the preformed metabolite, and after administration of amiodarone.
Shayeganpour A; Hamdy DA; Brocks DR
Biopharm Drug Dispos; 2008 Apr; 29(3):159-66. PubMed ID: 18161885
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic profile of ITF 296 in rats and dogs.
Monzani MV; Coltro G; Jiritano L; Sala A
J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S67-71. PubMed ID: 8839229
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, absorption and tissue distribution of tanshinone IIA solid dispersion.
Hao H; Wang G; Cui N; Li J; Xie L; Ding Z
Planta Med; 2006 Nov; 72(14):1311-7. PubMed ID: 17024606
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability and tissue distribution of anthocyanins in bilberry (Vaccinium myrtillus L.) extract in rats.
Ichiyanagi T; Shida Y; Rahman MM; Hatano Y; Konishi T
J Agric Food Chem; 2006 Sep; 54(18):6578-87. PubMed ID: 16939312
[TBL] [Abstract][Full Text] [Related]
13. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
14. Characterization of pharmacokinetic profiles and metabolic pathways of 20(S)-ginsenoside Rh1 in vivo and in vitro.
Lai L; Hao H; Liu Y; Zheng C; Wang Q; Wang G; Chen X
Planta Med; 2009 Jun; 75(8):797-802. PubMed ID: 19266426
[TBL] [Abstract][Full Text] [Related]
15. Main ginseng saponin metabolites formed by intestinal bacteria.
Hasegawa H; Sung JH; Matsumiya S; Uchiyama M
Planta Med; 1996 Oct; 62(5):453-7. PubMed ID: 8923812
[TBL] [Abstract][Full Text] [Related]
16. Absorption, distribution, metabolism and excretion of telmesteine, a mucolitic agent, in rat.
Lee J; Son J; Rhee SW; Kim DH
Xenobiotica; 2003 Jul; 33(7):755-65. PubMed ID: 12893524
[TBL] [Abstract][Full Text] [Related]
17. Comparison of pharmacokinetic and metabolic profiling among gossypol, apogossypol and apogossypol hexaacetate.
Jia L; Coward LC; Kerstner-Wood CD; Cork RL; Gorman GS; Noker PE; Kitada S; Pellecchia M; Reed JC
Cancer Chemother Pharmacol; 2008 Jan; 61(1):63-73. PubMed ID: 17356822
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of aminomethylpropanol in rats following oral and a novel dermal study design.
Saghir SA; Clark AJ; McClymont EL; Staley JL
Food Chem Toxicol; 2008 Feb; 46(2):678-87. PubMed ID: 17961896
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, biliary excretion, and tissue distribution of novel anti-HIV agents, cosalane and dihydrocosalane, in Sprague-Dawley rats.
Kuchimanchi KR; Udata C; Johnston TP; Mitra AK
Drug Metab Dispos; 2000 Apr; 28(4):403-8. PubMed ID: 10725308
[TBL] [Abstract][Full Text] [Related]
20. Oral idazoxan bioavailability in rat. Relevance of intestinal and hepatic first-pass effect.
Vallès J; Pruñonosa J; Menargues A; Nomen M; Obach R
Drug Metab Dispos; 1989; 17(6):673-6. PubMed ID: 2575506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
